<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">
Nasarawa State University, KeffiNasarawa State University, KeffiInstitutional Repository

EFFECT OF LEVERAGE ON FINANCIAL PERFORMANCE OF QUOTED PHARMACEUTICAL COMPANIES IN NIGERIA

Loading...
Thumbnail Image

Journal Title

Journal ISSN

Volume Title

Publisher

Accounting Department, Nasarawa State University, Keffi

DOI

Abstract

The study examines the effect of leverage on financial performance of quoted pharmaceutical companies in Nigeria over a period of 2006-2015. Five pharmaceutical companies quoted on the Nigeria Stock Exchange were examined. The study employs Debt Ratio (DR) and Debt to Equity ratio (DER) to proxy for financial leverage which serves as the independent variables and ROA as dependent variable of the study. Ex-post facto research design was used for study. Secondary data were obtained from financial statement of selected pharmaceutical companies listed on the Nigeria Stock Exchange (NSE). Descriptive statistics, correlation matrix, panel regression (Radom effect) were employed in the study. The results of the analysis showed that Debt Ratio has significant positive effect on Return on Asset (ROA) of pharmaceutical companies in Nigeria. While Debt to Equity (DER) has no significant effect on Return on Asset (ROA) of quoted pharmaceutical companies in Nigeria. The analysis also revealed that debt ratio has significant effect while debt to equity has no significant effect on return on asset of quoted pharmaceutical companies in Nigeria, when combined together. Based on the findings, the study recommends that the level of finance Debt ratio of quoted pharmaceutical companies in Nigeria should be increased since this study found that debt ratio has positive significant effect on the return on asset (ROA). The higher the debt ratio the more return on asset of quoted pharmaceutical companies in Nigeria. Debt to equity ratio was found be insignificant to the return on asset of pharmaceutical companies in Nigeria, it is recommended that the companies should reduce the level of debt to equity ratio of founding. The financial leverage of quoted pharmaceutical companies should be properly mix, owning to the fact that when debt and debt to equity ratios are combined, debt ratio contribute significantly to the return on asset of quoted pharmaceutical companies in Nigeria, while the debt to equity ratio is insignificant to return on asset. Therefore, the proportion of debt ratio should be higher than that of debt to equity ratio when combining the two ratios.

Description

Keywords

Citation

A DISSERTATION SUBMITTED TO THE SCHOOL OF POSTGRADUATE STUDIES, NASARAWA STATE UNIVERSITY, KEFFI, IN PARTIAL FULFILMENT OF THE REQUIRMENTS FOR THE AWARD OF MASTER OF SCIENCE (M.Sc.) DEGREE IN ACCOUNTING AND FINANCE

Endorsement

Review

Supplemented By

Referenced By